# LEVOMILNACIPRAN HYDROCHLORIDE
> **ANDA210771** · Abbreviated New Drug Application (Generic) · Sponsor: PRINSTON INC · Approved 2023-03-20
## Drug
- **FDA Application Number:** ANDA210771
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LEVOMILNACIPRAN HYDROCHLORIDE
- **Generic name:** Levomilnacipran Hydrochloride
- **Active ingredients:** LEVOMILNACIPRAN HYDROCHLORIDE
- **Dosage form:** CAPSULE, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** PRINSTON INC
- **First approval:** 2023-03-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210771)
---
*MORVS · CC0 1.0*